Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 54 publications
Pembrolizumab plus weekly paclitaxel in platinum-resistant recurrent ovarian cancer (ENGOT-ov65/KEYNOTE-B96): a multicentre, randomised, double-blind, phase 3 study.
Journal: Lancet (London, England)
Published: February 04, 2026
Advancing adoptive T cell therapy in ovarian cancer: barriers, innovations, and emerging platforms.
Journal: Journal for immunotherapy of cancer
Published: December 17, 2025
Reflections on Medical Trainee Unions and Health Care Systems.
Journal: JAMA
Published: September 25, 2025
Growing teratoma syndrome in a chemotherapy naïve patient.
Journal: Gynecologic oncology reports
Published: May 28, 2025
Mending the divide: integrating opioid analgesia and immunotherapy for optimal cancer care.
Journal: Journal for immunotherapy of cancer
Published: May 03, 2025
BiTE-secreting T cells rationally combine with PD-1 blockade and vaccine boosting to reshape antitumor immunity in ovarian cancer.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: March 20, 2025
mTOR inhibition modulates vaccine-induced immune responses to generate memory T cells in patients with solid tumors.
Journal: Journal for immunotherapy of cancer
Published: March 06, 2025
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN
Published: October 16, 2024
Prognostic significance of serum complement activation, neutrophil extracellular traps and extracellular DNA in newly diagnosed epithelial ovarian cancer.
Journal: Gynecologic oncology
Published: August 19, 2024
Tertiary lymphoid structures: exploring opportunities to improve immunotherapy in ovarian cancer.
Journal: Frontiers in immunology
Published: July 31, 2024
Last Updated: 09/26/2026